Answers are grounded in this paper and cite their sources.
Selenium is an essential micronutrient widely found in dietary supplements and fortified foods and is required for selenoprotein synthesis and function. Although the molecular mechanisms of selenium-dependent selenoprotein translation are well understood, its uptake mechanisms remain only partially characterized. Using a CRISPR-based loss-of-function screen, we identify the solute carrier SLC26A6 as a direct selenite transporter. Using biochemical, cellular, and in vivo studies, we show that SLC26A6 directly transports selenite and promotes selenoprotein translation, redox homeostasis, and ferroptosis resistance. Additionally, we report the first human-specific SLC26A6 inhibitor and determine the structure of the SLC26A6-inhibitor complex by cryo-electron microscopy. These findings identify a previously uncharacterized route of inorganic selenium uptake and establish SLC26A6 as a pharmacologically tractable determinant of selenoprotein synthesis, redox homeostasis, and ferroptosis resistance.
No takes yet. Share an insight, caveat, or question.
Atıcı et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: